RT Journal Article
SR Electronic
T1 Socioeconomic Disparities and COVID-19 Vaccination Acceptance: Experience from Israel
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.28.21250716
DO 10.1101/2021.01.28.21250716
A1 Gil Caspi
A1 Avshalom Dayan
A1 Yael Eshal
A1 Sigal Liverant-Taub
A1 Gilad Twig
A1 Uri Shalit
A1 Yair Lewis
A1 Avi Shina
A1 Oren Caspi
YR 2021
UL http://medrxiv.org/content/early/2021/02/01/2021.01.28.21250716.abstract
AB COVID-19 vaccination acceptance has a key role in mitigating the pandemic. Concern has been raised that vaccination rates will be limited in demographically defined areas of lower income. Israel’s rapid vaccination campaign may allow to assess these assumptions in real-world and to devise tools for effectively focusing the vaccination efforts. We analyzed the correlation between COVID-19 vaccination rates, socioeconomic status (SES) and active COVID-19 disease burden. We carried out a nationwide study, based on data provided by Ministry of Health of COVID-19 vaccination rates in all municipalities in Israel up to January 12th, 2021. Municipal Vaccination rates of population older than 60 significantly correlated with the socioeconomic status (r=0.83, 95% confidence interval [0.79 to 0.87]). Finally, we established a novel metric for focusing the vaccination efforts based on % vaccinations and active disease burden. In Israel, a case-model country for COVD-19 vaccinations, vaccination rates were strongly correlated with SES. The study findings demonstrate the need to directly target vaccination acceptance to socio-economically disadvantaged populations and suggest potential tools for policymakers to focus their efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunded by the Israel Ministry of Health and Mafat (Ministry of Defense).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB required by MOH.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request. Https://www.covid19maps.org